Welcome to HealthyDogPetCo Blog

Sitemap xml

Dev Cell. 2021 Sep 1:S1534-5807(21)00669-9. doi: 10.1016/j.devcel.2021.08.010. Online ahead of print. Dev Cell. 2021. PMID: 34496290

.
.
. Meschi S, et al. Clin Chem Lab Med. 2021 Sep 7. doi: 10.1515/cclm-2021-0700. Online ahead of print. Clin Chem Lab Med. 2021. PMID: 34492749 .
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. .
.

top
top
Page
Menu
News
top
Page
Menu
News
Home Print viewSitemap
 
top
Page
Menu
News